Company Performance: ZYZN.BE's financial health, including revenue, profit margins, debt levels, and growth prospects, directly impacts investor confidence and stock valuation.

Industry Trends: The overall performance and outlook of the biotech and pharmaceutical industry influence ZYZN.BE's stock price. Positive industry trends typically boost investor sentiment.

Market Sentiment: General investor mood, risk appetite, and broader economic conditions play a crucial role. Bull markets often lift most stocks, while bear markets can depress them.

Regulatory Environment: Changes in regulations, drug approval processes, or healthcare policies can significantly impact pharmaceutical companies like ZYZN.BE.

Clinical Trial Results: Positive clinical trial outcomes for ZYZN.BE's drug candidates usually drive the stock price up, while negative or inconclusive results can cause it to fall.

Competitor Activity: Actions by ZYZN.BE's competitors, such as new drug launches or acquisitions, can affect its market share and investor perception.

Management Changes: Significant changes in ZYZN.BE's leadership can introduce uncertainty and influence investor confidence.

Economic Factors: Macroeconomic factors like inflation, interest rates, and currency exchange rates can affect ZYZN.BE's operations and investor returns.

Global Events: Unexpected global events, such as pandemics or geopolitical crises, can create market volatility and affect ZYZN.BE's stock price.

Analyst Ratings: Recommendations and price targets from financial analysts can influence investor decisions and stock prices.